Mayer Eldon C. III

Avg. Two Year Performance

(17%) Avg. Purchase Return
(8%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return1%(3%)(16%)(22%)(17%)
Purchase Success Rate1 of 31 of 31 of 31 of 30 of 3
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 20 of 20 of 20 of 20 of 2

Rigel Pharmaceuticals, Inc.

Drugs » Drug Manufacturers - Major

EVP & Chief Commercial Officer:

Holdings: 215.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Eiger BioPharmaceuticals, I...

Drugs » Biotechnology

Ex VP & Chief Commerc. Officer:

Holdings: 56.07K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--